Increased serum visfatin as a risk factor for atherosclerosis in patients with ischaemic cerebrovascular disease

Singapore Medical Journal

Volumn 55, Issue 7, 2014, Pages 383-387

  Kong, Qingxia ^a   Xia, Min ^a   Liang, Ruqing ^a   Li, Lei ^a   Cu, Xu ^a   Sun, Zhuoxiang ^a   Hu, Junli ^a  

^a JINING MEDICAL UNIVERSITY   (China)

Author keywords

Adipocytokine; Atherosclerosis; Cerebral infarction; Ischaemic cerebrovascular disease; Visfatin

Indexed keywords

ADIPONECTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ADIPOCYTOKINE;

ACUTE LUNG INJURY; ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER FLOWMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HEMODIALYSIS; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RHEUMATOID ARTHRITIS; RISK FACTOR; SPINAL CORD INJURY; TRIACYLGLYCEROL BLOOD LEVEL; ADIPOSE TISSUE; BLOOD; BODY MASS; CASE CONTROL STUDY; CEREBROVASCULAR DISEASE; COMPLICATION; INFLAMMATION; METABOLISM; PATHOLOGY; STATISTICAL MODEL;

ADIPOKINES; ADIPOSE TISSUE; ADULT; AGED; ATHEROSCLEROSIS; BODY MASS INDEX; BRAIN ISCHEMIA; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RISK FACTORS;

EID: 84904750561     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: 10.11622/smedj.2014091     Document Type: Article

References (24)

1. Glass CK, Witztum JL. Atherosclerosis: the road ahead. Cell 2001; 104:503-16.
2. Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci 2009; 54:1847-56.
3. Samal B, Sun Y, Stearns G, et al. Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor. Mol Cell Biol 1994; 14:1431-7.
4. Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307:426-30.
5. Sommer G, Garten A, Petzold S, et al. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine. Clin Sci (Lond) 2008; 115:13-23.
6. Sonoli SS, Shivprasad S, Prasad CV, et al. Visfatin-a review. Eur Rev Med Pharmacol Sci 2011; 15:9-14.
7. Zhang LQ, Heruth DP, Ye SQ. Nicotinamide phosphoribosyltransferase in human diseases. J Bioanal Biomed 2011; 3:13-25.
8. Luk T, Malam Z, Marshall JC. Pre-B-cell colony-enhancing factor (PBEF)/ visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008; 83:804-16.
9. Dahl T, Yndestad A, Skjelland M, et al. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis. Possible role in inflammation and plaque destabilization. Circulation 2007; 115:972-80.
10. Adya R, Tan BK, Chen J, Randeva HS. Pre-B colony enhancing factor (PBEF)/visfatin induces secretion of MCP-1 in human endothelial cells: role in visfatin-induced angiogenesis. Atherosclerosis 2009; 205:113-9.
11. Kato A, Odamaki M, Ishida J, Hishida A. Relationship between serum pre-B cell colony-enhancing factor/visfatin and atherosclerotic parameters in chronic hemodialysis patients. Am J Nephrol 2009; 29:31-5.
12. Zhong M, Tan HW, Gong HP, et al. Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis. Clin Endocrinol (Oxf) 2008; 69:878-84.
13. Lu LF, Yang SS, Wang CP, et al. Elevated visfatin/pre-B-cell colony-stimulating factor plasma concentration in ischemic stroke. J Stroke Cerebrovasc Dis 2009; 18:354-9.
14. Li W. The fourth cerebrovascular diseases academic meeting of the Chinese Medical Association: Diagnostic points of various cerebrovascular diseases. Chinese J Neurol 1996; 29:379-80.
15. Mancia G, DeBacker G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28:1462-536.
16. Chen MP, Chung FM, Chang DM, et al. Elevated plasma levels of visfatin/ pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 2006; 91:295-9.
17. Chien KL, Su TC, Jeng JS, et al. Carotid artery intima-media thickness, carotid plaque and coronary heart disease and stroke in Chinese. PLoS One 2008; 3:e3435.
18. La Favor JD, Hollis BC, Mokshagundam SL, Olive JL. Serum hsCRP and visfatin are elevated and correlate to arterial stiffness in spinal cord-injured subjects. Spinal Cord 2011; 49:961-6.
19. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med 2005; 11:344-7.
20. Spiroglou SG, Kostopoulos CG, Varakis JN, Papadaki HH. Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. J Atheroscler Thromb 2010; 17:115-30.
21. Takebayashi K, Suetsugu M, Wakabayashi S, Aso Y, Inukai T. Association between plasma visfatin and vascular endothelial function in patients with type 2 diabetes mellitus. Metabolism 2007; 56:451-8.
22. Van derVeer E, Nong Z, O'Neil C, et al. Pre-B-cell colony-enhancing factor regulates NAD+ dependent protein deacetylase activity and promotes vascular smooth muscle cell maturation. Circ Res 2005; 97:25-34.
23. Liu SW, Qiao SB, Yuan JS, Liu DQ. Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf). 2009; 71:202-7.
24. Filippatos TD, Randeva HS, Derdemezis CS, Elisaf MS, Mikhailidis DP. Visfatin/PBEF and atherosclerosis-related diseases. Curr Vasc Pharmacol 2010; 8:12-28.